{"database": "lobbying", "table": "lobbying_activities", "rows": [[1730183, "02e6a849-bef8-4ee8-9c3e-d1319b1f0d5a", "Q3", "MILLER & CHEVALIER CHARTERED", 25306, "GLANBIA PERFORMANCE NUTRITION", 2015, "third_quarter", "AGR", "Legislative and regulatory policies impacting the dietary supplement industry.\nImplementation of Food Safety Modernization Act (P.L. 111-353); H.R. 1599 Safe and Accurate Food Labeling Act; Designer Anabolic Steroid Control Act of 2014 (PL 113-260).", "Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2015-10-14T11:30:17.257000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1730183"], "units": {}, "query_ms": 0.46094402205199003, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}